To Evaluate the Long-term Safety of (R,R)-Formoterol in Subjects With COPD

NCT00064415 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

799

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease
Chronic Bronchitis
Emphysema

Interventions

DRUG: arformoterol
DRUG: Salmeterol

Sponsor

Sumitomo Pharma America, Inc.